×
Schrodinger Price to Free Cash Flow Ratio 2019-2025 | SDGR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Schrodinger price to free cash flow ratio from 2019 to 2025. Price to free cash flow ratio can be defined as
View More
Schrodinger Price to Free Cash Flow Ratio 2019-2025 | SDGR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Schrodinger price to free cash flow ratio from 2019 to 2025. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$46.9B
Hims & Hers Health (HIMS)
$14.7B
Doximity (DOCS)
$11.1B
Tempus AI (TEM)
$10B
IRhythm Technologies (IRTC)
$4.5B
Inspire Medical Systems (INSP)
$3.9B
Hinge Health (HNGE)
$3.5B
Privia Health (PRVA)
$2.4B
10x Genomics (TXG)
$1.7B
Phreesia (PHR)
$1.6B
Enovis (ENOV)
$1.5B
Azenta (AZTA)
$1.5B
Clover Health Investments (CLOV)
$1.5B
Omnicell (OMCL)
$1.4B
Evolent Health (EVH)
$1.2B
Claritev (CTEV)
$636M
Fulgent Genetics (FLGT)
$532M
Standard BioTools (LAB)
$524M
Veradigm (MDRX)
$507M
Butterfly Network (BFLY)
$448M
Talkspace (TALK)
$418M
TruBridge (TBRG)
$315M
Outset Medical (OM)
$300M
Health Catalyst (HCAT)
$256M
Nyxoah SA (NYXH)
$243M
SOPHiA GENETICS SA (SOPH)
$212M
CapsoVision (CV)
$190M
Zepp Health (ZEPP)
$175M
KORU Medical Systems (KRMD)
$161M
Pulmonx (LUNG)
$127M